Stolz Brian M. 4
4 · BridgeBio Pharma, Inc. · Filed Nov 15, 2019
Insider Transaction Report
Form 4
Stolz Brian M.
Chief Operating Officer
Transactions
- Award
Common Stock
2019-11-13+22,839→ 22,839 total - Award
Stock Option (Right to Buy)
2019-11-13+102,081→ 102,081 totalExercise: $26.28Exp: 2029-11-12→ Common Stock (102,081 underlying) - Award
Restricted Stock Units
2019-11-13+106,469→ 106,469 total→ Common Stock (106,469 underlying)
Footnotes (3)
- [F1]The option shall vest and become exercisable as to 25% of the shares on October 7, 2020, and as to 1/48th of the shares each month thereafter for three additional years, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
- [F2]Restricted Stock Units are convertible to Common Stock on a 1 for 1 basis and have no expiration date.
- [F3]The units shall vest as to 25% of the units on November 16, 2020, and as to 1/12th of the units each quarter thereafter for three additional years, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.